Moderna rises 4% on optimism about RSV jab



Moderna Inc.’s stock rose above 4% on Wednesday, as investors drew optimism from the company’s announcement on the efficiency of the vaccine for respiratory syncytial virus or RSV.

According …

About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento